Head-to-Head

Moderna, Inc. Common Stock vs. Vaxcyte, Inc. Common Stock

MRNA

Moderna, Inc. Common Stock

$190.50 -6.25%

VS PCVX

Vaxcyte, Inc. Common Stock

$66.70 -9.65%

Moderna, Inc. Common Stock (MRNA) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

MRNAPCVX
Market Cap $81.13 billion $10.98 billion

MRNA leads on 1 of 1 size & scale factors.

Valuation

MRNAPCVX
Price / Book — 3.98

MRNA and PCVX split the valuation factors evenly.

Risk & Sentiment

MRNAPCVX
Short Interest 0.01% 0.13%

MRNA leads on 1 of 1 risk & sentiment factors.

Dig deeper: MRNA overview, MRNA financials, PCVX overview, PCVX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.